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1 Introduction 
 
1.1 Nucleophosmin 
Nucleophosmin (NPM1, also known as B23, Numatrin or NO38; Grisendi et 
al. 2006), was first identified as a nucleolar phosphoprotein expressed at high 
levels in the granular region of the nucleolus (Spector et al. 1984). NPM1 
was soon recognized to play a role in the regulation of cell growth, 
proliferation and transformation (Feuerstein et al. 1988), based on the 
observation that its expression rapidly increases in response to mitogenic 
stimuli, and that increased amounts of the protein are detected in highly 
proliferating and malignant cells (Chan et al. 1989). Since then, the 
understanding of NPM1 biology has considerably increased, revealing a 
complex scenario: NPM1 proved to be a multifunctional protein that is 
involved in many cellular activities, and which has been related to both 
proliferative and growth-suppressive roles in the cell (Di Fiore 2008). 
Furthermore, in the mouse, NPM1 is an essential gene whose inactivation in 
the germ line leads to a series of developmental defects and embryonic 
lethality at mid-gestation (Grisendi et al. 2005). 
Much of the interest in NPM1 has been fostered by the fact that this gene is 
implicated in human tumorigenesis. On the one hand, NPM1 is frequently 
over-expressed in solid tumors of diverse histological origin, whereas on the 
other hand, the NPM1 locus is involved in chromosomal translocations or 
deleted in various kinds of haematological malignancies and solid tumors. 
Strikingly, NPM1 has also been found mutated and aberrantly localized in the 
cytoplasm of leukaemic blasts in a high proportion (around 35%) of patients 
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with acute myeloid leukaemia (AML) (Falini et al. 2005). This makes of 
NPM1 the most frequently mutated gene in AML. 
 
1.2 Nucleophosmin is a nuclear-cytoplasmic shuttling protein  
NPM1 is a ubiquitously expressed protein belonging to the nucleoplasmin 
family of nuclear chaperones (Frehlick et al. 2007). It is encoded by the 
NPM1 gene that, in humans, maps to chromosome 5q35 (Chan et al. 1989). 
Three nucleophosmin isoforms are generated through alternative splicing. 
NPM1 (or B23.1), the dominant isoform (accession n. NM_002520) (Wang 
et al. 1993), is a 294-amino acid phospho-protein of about 37 kDa that is 
expressed in all tissues. NPM1.2 (or B23.2) uses an alternative terminal exon 
compared with variant 1, resulting in a 259-amino acid protein (accession n. 
NM_001037738) with a distinct C-terminus and it accounts for minimal 
nucleophosmin content in tissues. A third variant (accession number 
NM_199185) lacks an alternate in-frame exon compared with variant 1, 
resulting in a shorter protein whose functions and expression pattern are still 
under investigation. Interestingly, NPM1 (B23.1) and NPM1.2 (B23.2) have 
different subcellular distribution patterns (Wang et al 1993): while NPM1 
protein is localized mainly in the nucleolus (Spector et al. 1984, Cordell et al. 
1999), NPM1.2 is only found in the nucleoplasm (Dalenc et al. 2002). NPM1 
contributes to build-up the nucleolar compartment of which it is one of the 
most abundant protein components among the approximately 700 identified 
by proteomics (Ahmed et al. 2009).  
Despite its nucleolar localization, experiments on NPM1 migration provided 
conclusive evidence that the protein shuttles constantly back and forth 
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between nucleus and cytoplasm (Borer et al. 1989). However, the flux of 
nucleophosmin at the nucleolus–nucleoplasm interface is unbalanced towards 
the nucleolus. This is the consequence of the very efficient nucleolar-
localization signal (NoLS) that NPM1 contains at its C-terminus. 
Nuclear-cytoplasmic shuttling of NPM1 is critical for most of its functions, 
including regulation of ribosome biogenesis and control of centrosome 
duplication (Grisendi et al. 2006). NPM1 shuttles across cytoplasm and 
nucleoplasm as well as between nucleoplasm and nucleolus. Distinct NPM1 
functional domains regulate its different activities as well as its shuttling 
properties.  
 
1.3 Nucleophosmin functional domains 
The NPM1 polypeptide chain has a modular structure containing distinct 
sequence motifs. Various functional domains that reside in mainly 
independent, but slightly overlapping segments, have been identified within 
the protein (Fig. 1.1). 
 
 
 
 
 
 
 
 
Fig. 1.1 Structural and functional organization of NPM1, the different portions of  
the protein and their respective function are depicted in a colour coded 
representation. (adapted from Grisendi et al., 2006) 
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Starting from the N-terminus, the protein contains a nucleoplasmin-like 
domain that is involved in protein oligomerization and chaperone activities, 
followed by two acidic stretches that are important for binding to histones. 
The central portion between the two acidic stretches is required for 
ribonuclease activity, together with the C-terminal domain, which contains 
basic stretches involved in nucleic-acid binding (Hingonari et al. 2000). The 
basic clusters are followed by an aromatic stretch, which contains two 
tryptophan residues (288 and 290) that are required for nucleolar localization 
of the protein (Nishimura et al.2002). In addition, NPM1 includes a nuclear-
localization signal (NLS), and a nuclear-export signal (NES) (Wang et 
al.2005). As stated above, the N-terminal domain of NPM1 share 50% 
homology with the Xenopus laevis protein nucleoplasmin (Chan et al. 1989; 
Borer et al. 1989). Nucleoplasmins are nuclear chaperone proteins that 
function as histone assembly and chromatin decondensation factors. Their 
main function is to bind to core histones and transfer DNA to them in a 
reaction that does not require ATP. All the members of this protein family 
share a similar core region in the N-terminal half (nucleoplasmin domain), 
and one or more acidic domains rich in aspartic and glutamic acid residues. 
Compared with other members of the family, NPM1 possesses additional 
domains and functions in the C-terminal region, such as ribonuclease 
enzymatic activity and a nucleic-acid binding domain. 
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1.4 Nucleophosmin: Physiological role 
By shuttling between cellular compartments, NPM1 takes part in various 
cellular processes. These include the transport of pre-ribosomal particles and 
ribosome biogenesis (Olson et al. 1986), the response to stress stimuli such as 
UV irradiation and hypoxia (Li et al. 2004; Wu et al. 2002), the maintenance 
of genomic stability through the control of cellular ploidy (Naoe et al. 2006) 
and the participation in DNA-repair processes (Wu et al. 2002), and the 
regulation of DNA transcription through modulation of chromatin 
condensation and decondensation events (Wang et al. 1994; Dumbar et al. 
1989). 
Finally, NPM1 is involved in regulating the activity and stability of crucial 
tumour suppressors such as p53 and p14ARF (Bertwistle et al. 2004; Kurki et 
al. 2004; Colombo et al. 2006; Bolli et al. 2009) and oncogene products such 
as c-MYC (Boon et al. 2001; Yung 2004; Zeller et al. 2001). 
One main feature of NPM1 is its ability to function as a molecular chaperone 
for both proteins and nucleic acids (Szebeni and Olson 1999; Okuwaki et al. 
2001). In vitro experiments on various protein substrates have shown that 
NPM1 is active in preventing the aggregation of proteins in the congested 
cellular environment (Szebeni and Olson 1999), and that it functions as a 
histone chaperone that is capable of histone assembly, nucleosome assembly 
and increasing acetylation-dependent transcription (Okuwaki et al. 2001). 
Through its molecular domains, NPM1 is able to bind to many partners in 
distinct cellular compartments, including nucleolar factors (for example, 
nucleolin, fibrillarin and snoRNPs), transcription factors (for example, 
interferon regulatory factor 1 (IRF1), YY1 and nuclear factor kB (NFkB)), 
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histones (for example, H3, H4 and H2B), proteins involved in cell 
proliferation (for example, DNA polymerase), mitosis (for example NUMA) 
and proteins involved in response to oncogenic stress (for example, p14ARF 
and p53) (all reviewed in Grisendi et al. 2006). In addition NPM1 has been 
reported to bind both the oncogenic protein c-MYC (Boon et al. 2001) and its 
E3-ubiquitin ligase Fbw (
cytoplasm, interactions with caspases 6 and 8 (Leong et al. 2010) and with 
proteins belonging to the Fanconi anemia complex have been reported (Li et 
al. 2007).  
Eventually, NPM1 is able to associate with the second messenger 
phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) in the nucleus in response 
to anti-apoptotic factors (Ahn et al. 2005). 
The diversity of the cellular activities in which NPM1 is involved in makes it 
both a potential oncogene and a potential tumour suppressor, depending on 
the expression levels and the cellular context. 
 
1.5 Structural features of Nucleophosmin 
Under native conditions, NPM1 exists as an oligomer (Herrera et al. 1996): 
the structure of the Xenopus laevis nucleoplasmin family member NO38 
(Spector et al. 1984), a nucleolar histone chaperone that is highly 
homologous to human NPM1, appears to be able to form pentamers and 
decamers (Naboodiri et al. 2004). 
More recently the crystal structure of human NPM1 N-terminal domain was 
determined and confirmed that a crown-shaped pentamer is formed by this 
core domain, with two pentamers loosely associating to form a head-to-head 
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dimer of pentamers that account for the fairly large molecular weight of 
appromatively 300 KDa (Lee et al. 2007) (Fig. 1.2). 
                                                                                            
 
Fig. 1.2 Organization of Nucleophosmin N-terminal domain.  
 
The ability of NPM1 N-terminal domain to form oligomers is involved in its 
translocation to the nucleolus. Indeed, artificial NPM1 mutants that contain 
the nucleolar-binding domain but are unable to form oligomers cannot enter 
the nucleolus, suggesting that the NoLS load of the particle has to reach a 
threshold to enable nucleolar localization (Bolli et al. 2007).  
 The structure of NPM1 C-terminal domain was solved by NMR 
spectroscopy (Grummitt et al. 2008) and consists of a well-defined 3-helix 
right-handed bundle (Fig. 1.3).  
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Fig. 1.3 NMR 3D structure of NMP1-Cter (pdb code, 2VXD). The two tryptophans 
at positions 288 and 290 are highlighted in sticks. 
 
The central region of NPM1, which is endowed with many protein’s function 
including histone binding and ribonuclease activity, is predicted to be 
natively unstructured by the vast majority of predictive algorithms (Hingonari 
et al. 2000). 
 Finally and importantly, several post-translational modifications have 
been reported, including phosphorylation, ubiquitination and SUMOylation, 
and may contribute to the final shape of the protein, regulate the cellular 
traffic of NPM1 and its functions (Colombo et al., 2011).  
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1.6 NPM1 is altered in human cancer 
NPM1 has been directly implicated in human tumorigenesis. The NPM1 
protein is overexpressed in a variety of tumours, and it has been proposed as 
a marker for gastric (Tanaka et al. 1992), colon (Nozawa et al. 1996), ovarian 
(Shields et al. 1997) and prostate carcinomas (Subong et al. 1999). In some 
cases, the expression levels of NPM1 have been correlated with the stage of 
tumour progression. For instance, overexpression of NPM1 mRNA is 
independently associated with the recurrence of bladder carcinoma and 
progression to a more advanced stage of disease (Tsui et al. 2004). On the 
other hand, NPM1 is one of the most frequent targets of genetic alterations in 
haematopoietic tumours. Two well-characterized genomic events that involve 
the NPM1 gene are chromosomal translocations in both lymphoid and 
myeloid disorders (Raimondi et al. 1989, Redner et al. 1996), and mutations 
in Acute Myeloid Leukemia (AML) (Falini et al. 2005). 
NPM1 alterations lead to the formation of either oncogenic fusion proteins or 
mutant NPM1 products, and to the concomitant loss of one functional allele 
of the gene (Berger et al. 2006). The role of the NPM1 moiety in the various 
chimeric products (NPM1–ALK (anaplastic lymphoma kinase), NPM1–RAR 
(retinoic acid receptor) and NPM1–MLF1 (myelodysplasia/myeloid 
leukaemia factor1)) is not fully characterized, and it is conceivable that 
NPM1 might serve as a homo- or heterodimerization interface (Bischof et al. 
1997). 
 In 2005, Falini and coworkers identified heterozygous NPM1 
mutations as the most common genetic lesion in adult acute myeloid 
leukaemia (AML) (about 30% of cases) (Falini et al. 2005). They 
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subsequently provided evidence that AML with mutated NPM1 exhibits 
distinctive biological and clinical features (Falini et al. 2007) that supported 
its inclusion as a provisional entity in the new WHO classification (Falini et 
al. 2009).  
Approximately 40 NPM1 mutations have been identified to date (Falini et al. 
2009), and despite their heterogeneity they all lead to similar abnormalities in 
the mutated protein. Mutations all consist of short base sequence duplications 
or insertions at the terminal exon of the gene (Fig. 1.4). These lead to a shift 
in the reading frame, and a consequent alteration in the protein sequence 
which is longer by four residues and different in the last seven of the 
reference one. Notably both W288 and W290 are replaced in the most 
common mutants, while W288 is retained in less frequent mutations (Fig. 
1.4). 
 
 
 
 
 
 
 
 
Fig. 1.4 Representative NPM1 mutations and their consequences on protein 
sequence. 
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The salient feature of all mutated genes is that they generate a variant protein 
that is aberrantly localized in leukaemic blast cytoplasm (Nakagawa et al. 
2005) (Fig. 1.5). This varied distribution of NPM1 mutants in AML cells is 
due to the concerted action of tryptophans loss, with the alteration of the so-
called nucleolar localization signal, and the generation of a new nuclear 
export signal (NES) motif at the NPM1 protein C-terminus (Falini et al. 
2006). Under normal conditions, the two tryptophans are critical for keeping 
the C-terminus globular domain of wild-type NPM1 folded (Grummitt et al. 
2008, Scaloni et al., 2009-2010), and this in turn appears essential for NPM1 
binding to the nucleolus. In leukaemic cells, mutation-induced tryptophan 
changes unfold the domain and consequently impair NPM1 targeting to the 
nucleolus (Grummitt et al. 2008).  
The expression of NPM1 fused to GFP in mammalian cells allowed the direct 
observation of its sub-cellular localization (Dundr et al. 2000). This approach 
proved to be extremely powerful to evaluate the effect of leukaemic 
mutations on the cellular distribution of the protein. In particular, two 
designed point-mutants, W288A and W290A, were shown to lead to loss of 
nucleolar localization and to the accumulation of the protein in the 
nucleoplasm (Falini et al. 2006; Nishimura et al. 2002). Indeed, it was later 
shown that the NPM1 C-terminal domain with W288 and W290 mutated to 
alanine lacked any distinct tertiary structure and did not undergo a 
cooperative unfolding transition when heated (Grummitt et al. 2008). This 
suggested that mutation of these residues prevents nucleolar localization 
simply by preventing the correct folding of the C-terminal domain of NPM1. 
In order to test this hypothesis other mutations in the C-terminal domain that 
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would be expected to disrupt its structure whilst retaining the tryptophans 
were produced (Grummitt et al. 2008). The sub-cellular localization of these 
mutants transfected into NIH-3T3 cells was indeed nucleoplasmic and not 
nucleolar, suggesting the fundamental role of correctly folded C-terminal 
domain for nucleolar localization (Falini et al. 2006).  
Cytoplasmic accumulation of NPM1 leukaemic mutants also depends upon 
the NES motifs. Two of them are physiological and are located at the N-
terminus (corresponding to residues 42–49 and 94–102) (Wang et al.2005). 
The third motif is introduced by the mutational event at the NPM1 C-
terminus (residues 287–296) (Falini et al. 2005).  However, it is not yet clear 
how much each of the three NES motifs contributes to mutant protein nuclear 
export (Bolli et al. 2009) (Fig. 1.4). 
 
 
 
 
 
 
 
Fig. 1.5 Ectopic aberrant localization of mutated NPM1 in the cytoplasm. Left 
panel: GFP-tagged wild-type NPM1 localizes in nucleoli inside the nucleus. Right 
panel: GFP-tagged mutated NPM1 aberrantly localizes outside the nucleus in the 
cytoplasm. Red stain highlights the nuclear membrane. 
 
One important feature to be highlighted is that, although NPM1 mutations are 
always heterozygous, the mutated protein has a dominant negative effect on 
wild-type localization. In fact, mutated NPM1 is still capable to interact with 
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the wild-type protein, through its unchanged N-terminal domain, and to form 
mixed oligomers that are, in great part, localized in the cytoplasm. 
 
1.7 Nucleophosmin interacts with nucleic acids 
The NPM1 C-terminal domain is responsible for the nucleic acid binding 
activity. NPM1 was shown to bind both DNA and RNA oligonucleotides 
with a preference for single-stranded structures over double-stranded DNA B 
structures, in a sequence-unrelated manner (Wang et al.1994; Dumbar et al. 
1989). Accordingly, a role for NPM1 as a single-stranded binding protein 
(ssb) was proposed (Dumbar et al. 1989), a property that may be linked to the 
export of ribosome subunits from the nucleus (Falini et al. 2009). NPM1 was 
also reported to have endoribonuclease activity on ribosomal RNA (rRNA) 
(Savkur and Olson 1998; Herrera et al. 1995). Recently, the protein was also 
identified as a cofactor in the transcriptional activation of the mitochondrial 
superoxide dismutase 2 (SOD2) gene; in particular it was shown that full-
length NPM1 binds a G-rich region at the SOD2 promoter (Xu et al. 2007), 
shedding new light on NPM1 possible role in transcriptional regulation 
through its interaction with G-rich promoter regions. 
G-rich sequences have the potential to form non-canonical DNA secondary 
structures, called G-Quadruplexes, under physiological conditions (Gellert et 
al. 1962). Different studies are increasing our attention on non-canonical 
DNA conformations, describing their structures, interacting partners and 
potential biological roles (Phan et al. 2006, Sen and Gilbert 1988). As well as 
on the non-canonical secondary structures (with particular attention to G-
quadruplexes), different studies in the last few decades underlined the 
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increasingly important role of DNA G-rich binding proteins focusing 
attention on how they interact, and how this interaction may regulate 
different cellular processes (Fry 2007). In fact experimental evidence 
corroborates the reasonable assumption that regulated interactions of G-rich 
DNA sequences with different proteins may alternatively cause formation, 
stabilization, destabilization, unwinding or selective nucleolytic digestion of 
G-quadruplex sequences, suggesting key roles for these interactions in the 
cell (Fry 2007).  
 
1.8 G-Quadruplex 
Nowadays, it is becoming increasingly evident that non-Watson-Crick 
interactions between bases and non-canonical DNA secondary structures 
have biological roles, with particular reference to Guanine-rich nucleic acid 
sequences that are able to form higher order secondary structures: the so 
called guanine-quadruplexes (G-Quadruplexes). Observations starting from 
1960s established that a synthetic guanosine 5’-monophosphate (GMP) has 
the ability to form helical aggregates under physiological-like in-vitro 
conditions of pH, temperature and salt concentrations (Gellert et al. 1962). 
These initially inexplicable finding was explained in the late 1980s when 
biochemical experiments demonstrated that oligonucleotides containing runs 
of three or four adjacent guanines (G-tracts), spontaneously can fold in a 
valet of four-stranded formations called tetraplex or quadruplex (Sen and 
Gilbert 1988, Williamson et al. 1989).  
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A            B       
                   
Fig.1.6 (A) Watson–Crick base-pairing. (B) Four guanines can hydrogen bond in a 
square arrangement to form a guanidine tetrad. There are two hydrogen bonds on 
each side of the square. 
 
These non-canonical structures are composed of four or more Guanine-tracts 
(G-tracts), which are able to form stacking guanine tetrads, where the tetrads 
stack on top of each other. The guanines within the tetrad interact via 
Hoogsteen hydrogen bonds between the N1, N7, O6 and N2 guanine atoms 
and are stabilized by monovalent cations such as potassium or sodium (Qin et 
al. 2008) (Fig.1.6B). These guanine tetrads are the basic building block of G-
Quadruplexes, and contribute to their secondary structure and stability by 
guanidine tetrads’ large π-surfaces, that tend to stack on each other due to π- 
π stacking interactions, with stabilizing monovalent cation intercalated 
between tetrads (Gilbert et al. 1999) (Fig.1.7). 
By definition G-Quadruplex is a DNA secondary structure that consist of 
multiple vertically stacked guanidine tetrads stabilized by alkali ion, most 
commonly K
+
 or Na
+
 (Sen et al. 1990). K
+
 and Na
+
 effectively bind to and 
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stabilize many G-Quadruplex structures and in particular K
+
 shows a higher 
stabilizing activity, with respect to Na
+
, due to the better coordination of K
+
 
with the eight carbonyl oxygen atoms present in the adjacent stacked tetrads 
(Sen et al. 1990). Moreover K
+
 and Na
+
 are the prevalent alkali ions in the 
cell environment underlining that physiological conditions are favorable for 
G-Quadruplex formation. A variety of G-Quadruplex structures have been 
determined using X-ray crystal diffraction and NMR analysis (Kang et al. 
19992, Smith and Feigon 1992, Wang and  Patel 1993, Kettani et al. 1995). 
These studies led to classify quadruplexes into three majors groups: 
unimolecular, bimolecular and four-molecular Quadruplexes. Furthermore, 
depending on direction of the strands, may assume different topologies 
described as parallel, antiparallel or mixed. 
 
 
        
 
Fig. 1.7 Structure of a G-tetrad and an example of the folding pattern of 
intramolecular G-quadruplex 
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1.9 G-Quadruplexes: biological role 
Data gathered in last decades are focusing attention on G-Quadruplexes, and 
in particular mounting evidence indicates that these secondary structures 
exist in vivo and play a number of biological functions. 
For many years there was minimal evidence pointing towards biological role 
of G-Quadruplex structures, until it was discovered that the ends of human 
chromosomes, the telomeres, are composed of tandem repeats of G-rich DNA 
sequence: d(TTAGGG) (Moyzis et al. 1988). Subsequent work demonstrated 
the ability of these sequences to form intramolecular G-Quadrupexes, and 
how these structures can regulate Telomerase activity (Wang and Patel 1993, 
Zahler et al. 1991). In fact formation of quadruplexes at telomere’s ends 
directly inhibits Telomerase activity, preventing telomeres elongation and 
impacting on cellular senescence and cell cycle regulation. Telomerase 
activity is directly implicated in more then 85% of cancer processes, where it 
is over-expressed contributing to cancer cells immortalization. These data 
describe a direct regulating role of a G-Quadruplex structure in pathological 
process, shedding a new light and suggesting a possible functional role for 
this non-canonical secondary structure. 
Starting from studies of G-Rich 3’overhanging in human telomere and 
Telomerase  relationship, both in pathological and physiological conditions, 
extensive research effort has been devoted to investigate the relevance of 
potential function of DNA G-Quadruplex in biology. 
Many computational studies have been carried out to identify G-rich 
sequences with potential to form G-Quadruplex secondary structures 
(Putative Quadruplex Sequence, PQS) in the human genome and other 
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genomes. These studies showed that the human genome contains as many as 
376000 PQS (Putative Quadruplex Sequence; Huppert and Balasubramanian 
2005). Although the occurrence of PQS in genomes is a third less than 
expected by chance (Huppert and Balasubramanian 2007), their location 
seems to be non-random (Zhao et al. 2007). The highest occurrence of PQS is 
in non-coding repetitive DNA regions such as telomeres, hyper-recombining 
sites and, interestingly, in promoter regions of eukaryotic genes with over 
40% of human gene promoters containing at least one PQS, emphasizing G-
Quadruplex potential regulatory role (Huppert and Balasubramanian 2007). 
Different studies identified PQS that are able to form G-Quadruplex in vitro,  
in promoter regions of different human genes, with particular attention to 
important proto-oncogenes like c-Myc (Suddiqui et al. 2002), VEGF (Sun et 
al. 2005), HIF-1α (De Armound et al. 2005), Ret (Guo et al. 2007), KRAS 
(Cogoi et al. 2006), Bcl-2 (Dexheimer et al. 2006), c-Kit (Rankin et al. 2007), 
PDGF-A (Qin et al. 2007) and c-Myb (Lee et al. 2008). Generally the 
proximal regions of these promoters are GC-rich regions and usually are 
hypersensitive to nuclease and may form an altered structure with a single 
stranded character which is often a feature of transcriptionally active genes 
(Sun et al. 2005). 
This association of G-Quadruplex with gene promoters was consistent with 
the hypothesis of linking G-Quadruplexes formation with transcriptional 
control of genes (Simonson et al. 1998). Subsequently, different studies 
showed that mutations that destabilize G-Quadruplex structure in promoter 
regions led to an increased in transcription activity (Siddiqui-Jain 2002). This 
has led to suggestions that G-Quadruplexes play a key-role in the regulation 
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of gene expression through formation or resolution of specific Quadruplex 
structures, thus describing these DNA non-canonical secondary structures as 
a cis-acting regulatory elements. 
One of the better characterized G-Quadruplex forming sequence is the one in 
c-Myc oncogene promoter region. The c-Myc protooncogene encodes a 
multifunctional transcription factor that plays a critical role in different 
cellular processes such as regulation of cell cycle progression, cell growth, 
differentiation, transformation, angiogenesis, and apoptosis (Oster et al. 
2002). c-MYC is able to activate a number of genes by forming  complexes 
with other transcription factors such as MAX or MAD that interact with 
specific DNA sequences, such as the E-box sequence (Grandori et al. 2000). 
Overexpression of c-MYC is associated with a significant number of human 
malignancies, including breast, colon, cervix, and small-cell lung cancers, 
osteosarcomas, glioblastomas, and myeloid leukemias (Facchini et al. 1998). 
c-Myc transcription is usually subject to tight transcriptional regulation and it 
is under the complex control of multiple promoters. The promoter region of 
c-Myc contains a number of cis-elements that have been shown to assume 
either a single-stranded or a non–B-DNA conformation; in particular there 
are seven nuclease hypersensitive elements (NHEs) in the c-Myc promoter, 
and one of these, the NHE III1 region, has been shown to have the ability to 
form non–B-DNA structures. This region is located from  –1 to –115 base 
pairs upstream of the P1 promoter and has been shown to control up to 90% 
of the total c-MYC transcription (Berberich et al. 1995). The NHE III1 in c-
Myc contains a 27-base pair G-rich sequence (c-Myc-27-mer) at the non-
coding strand that is capable of engaging in a slow equilibrium between B-
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form duplex DNA, single-stranded DNA, and G-Quadruplex (Gonzàles et al. 
2010). Quadruplex formation in NHE III1 induce a complete silencing of c-
Myc transcription (Siddiqui-Jain et al. 2002), suggesting the importance of 
this regulatory mechanism based on equilibrium between formation and 
resolution of this DNA non-canonical secondary structures. Biological 
significance of the intramolecular G-Quadruplex structure formed in c-Myc 
NHE III1 has been evaluated also in two Burkitt’s lymphoma cell lines, 
confirming G-Quadruplex transcriptional inhibitory activity (Siddiqui-Jain et 
al. 2002). 
Furthermore, different proteins contribute to transcriptional regulation 
favoring G-Quadruplex formation or resolution. Different studies identified 
many proteins that could functionally interact with non-canonical DNA 
conformation shedding light on the importance of these structures with 
particular attention to G-Quadruplex (Fry 2007).     
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2 Aim of the thesis 
The Nucleophosmin C-terminal domain is the portion of the protein that is 
altered by NPM1 gene mutations in Acute Myeloid Leukemia. This domain, 
which consists of a three-helix bundle, as recently revealed by NMR 
spectroscopy (Grummitt et al. 2008), is largely destabilized or totally 
unfolded in the leukogenic variant protein, due to a change in the gene 
reading frame that results in a protein that is longer by four residues and with 
a different sequence in the last seven. Two main variations result from the 
mutational event: i) the loss of one or both of two critical tryptophan residues 
in the hydrophobic core of the three helix bundle, which accounts for the 
dramatic loss of stability of the domain (Scaloni et al. 2010) and ii) the 
appearance of a new Nuclear Export Signal at the C-terminus of the protein. 
Both variations concur to the aberrant translocation of the protein in the 
cytosol, which is the hallmark of this kind of leukemia. 
 The NPM1 C-terminal domain has been known for a long time to be 
responsible for the nucleic acid binding properties of the protein. It was 
shown that NPM1 binds both RNA and DNA, with a preference for single 
stranded nucleic acids and with no specific sequence requirements (Hingorani 
et al., 2000).  
 Because leukemic mutant NPM1 is stably localized in the cytoplasm, 
we decided to further investigate the DNA binding properties of the protein, 
assuming that some important function related to nucleic acid binding in the 
nucleus might be impaired in these mutants. 
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This task, which was the initial aim of my Ph.D. work, was tackled through 
the combination of different spectroscopic techniques and probing NPM1 C-
terminal constructs of different lengths and a variety of site-directed mutants. 
Importantly these studies revealed that, although capable of binding any 
DNA oligo with low affinity, NPM1 C-terminal domain displays higher 
binding affinity for oligos capable of assembling as G-quadruplexes. Since 
the first rather serendipitous observation of this feature, my experimental 
work was directed towards the full characterization of NPM1 as a novel G-
quadruplex binding protein. 
Having established the preference of NPM1 for G-quadruplex DNA regions, 
the next step of my experimental work was to structurally characterize the 
complex formed by the NPM1 C-terminal domain and a representative G-
Quadruplex from the oncogene c-MYC promoter. This aim was particularly 
intriguing to us, both because of its possible implications in understanding 
NPM1 biology, but also because structural information about how proteins 
recognize G-quadruplex DNA is very limited. This task was achieved with 
the use of several NMR techniques and working in collaboration with Prof. 
Ivano Bertini and Prof. Lucia Banci, at CERM-University of Florence, where 
I spent the last year of my Ph.D. period.  
 In summary this thesis reports a detailed characterization of NPM1 
DNA binding properties and a structural investigation of a representative 
NPM1-G-quadruplex complex. 
 I believe that these studies may provide a useful conceptual 
framework to better understand some of the biological functions played by 
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this highly pleiotropic protein and their loss in the aberrantly cytoplasmic 
localized variant protein. 
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3 Results 
3.1 NPM1 interaction with DNA 
It is well known that NPM1 C-terminal domain is able to bind both DNA and 
RNA, with a preference for single stranded oligonucleotides over duplexes 
and with no specific sequence requirements (Hingorani et al., 2000). This 
behavior suggested that NPM1 nucleic acid binding activity may serve for 
NPM1-mediated ribosome transfer to the cytosol. 
Recently, however, it was demonstrated that full-length NPM1 can interact 
with a specific G-rich sequence present in SOD2 promoter region and it was 
suggested that, through this recognition event, the protein is directly involved 
in the transcriptional activation machinery, functioning as a positive regulator 
of  the SOD2 gene, by mediating the interaction between enhancer and 
promoter regions (Xu et al. 2007). This promoter region is predicted to fold 
in a hairpin with a five paired-bases stem and a stretch of ten consecutive 
Guanines that form a loop (hereby named G-10 loop; Fig. 3.1B). By 
interfering with base-pairing in the wild type sequence or eliminating the 
loop, NPM1 is unable to bind the promoter region, preventing gene 
transcription, and thus indicating a direct connection between promoter 
region structure, NPM1 binding and gene transcription (Xu et al. 2007).  
Our first aim was to confirm that the DNA binding activity of the G-10 loop 
could be mapped to the C-terminal domain of the protein, as previously 
reported in literature  for unstructured oligos (Hingorani et al., 2000), and to 
better define the boundaries of the DNA binding domain. To this purpose, a 
biotynilated version of the G10-loop was immobilized on a streptavidin chip 
and used as bait in Surface Plasmon Resonance analysis. Two different 
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constructs of the NPM1 C-terminal domain were used as the analytes: 
NPM1-C70 comprising the last 70 C-terminal residues, and NPM1-C53 
comprising the last 53 residues, (Fig. 3.1 A). The first construct was chosen 
because previous binding data on truncated proteins mapped the NPM1 
nucleic acid binding activity to this segment (Wang et al. 1994; Hingorani et al. 
2000), whereas NPM1-C53 was chosen because it is the minimal folding unit 
of the C-terminal domain (Scaloni et al. 2009), which adopts a stable three 
helix bundle structure (Grummitt et al. 2008).  
      
 
Fig. 3.1 Protein constructs and DNA oligos used in this study. A) Sequence of the 
C-terminal domain of NPM1. The region differentiating NPM1-C70 from NPM1-
C53 (whose 3D structure is shown in the inset) is underlined. Mutated lysines are 
shown in bold. The PSIPRED prediction is also shown (C=coil, H=α-helix, E=β-
strand).B) Oligos used in this study are shown both in sequence and in putative 
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structure. 
 
When testing NPM1-C70 as the analyte we obtained a KD = 7.2 µM (Fig. 3.2 
A, Table 3.1) while with NPM1-C53 we obtained a KD = 169 µM (Fig. 3.2 B, 
Table 3.1). Interestingly, both the association and dissociation rate constants 
could be determined when NPM1-C70 was the analyte (Fig. 3.2 A), while 
they were too rapid to be determined with NPM1-C53 (Fig. 3.2 B).  
This result suggests that the nucleic acid binding site is altered in the shorter 
protein construct and that, in this case, binding is mainly dictated by 
electrostatic interactions of the positively charged protein domain (Fig. 3.1) 
with the negatively charged G10-loop. 
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Fig. 3.2 SPR sensorgrams of the interaction between G10-loop and NPM1 
constructs. The oligo, biotynilated at its 5’ end, was immobilized on a SA 
(streptavidin) sensor chip. A) experimental curves (dashed lines with circles) 
represent different concentrations of NPM1-C70 used as the analyte and were fitted 
according to a single exponential binding model with 1:1 stoichiometry (continuous 
lines). B) experimental curves represent different concentrations of NPM1-C53. 
Both on and off rates were too rapid to be resolved, C) Scatchard plot used to 
determine the dissociation constant with NPM1-C53. 
 
Next, we wanted to determine the structural properties of the DNA hairpin 
necessary for binding NPM1. To this end we first tested a so-called T10-loop, 
where the ten guanines at the loop of the G10-hairpin are replaced by ten 
thymines, while all the other bases are conserved (Fig. 3.1 B). With NPM1-
C70 we obtained a KD = 307 µM that increased to KD = 1.17 mM with 
NPM1-C53 (Table 3.1). This experiment indicates that a sequence that forms 
a hairpin structure resembling that of the native G10-loop but with thymines 
instead of guanines at the loop is poorly recognized, with a 42-fold lower 
affinity. NPM1-C53 is indeed poorly competent for binding.  
To explore the dimensional requirements of the hairpin for high affinity 
recognition, we next immobilized a G5-loop, which maintains the same 
hairpin arrangement of the G10-loop but with only five guanines in the loop 
(Fig. 3.1 B). With this oligonucleotide, we obtained a KD = 40 µM with 
NPM1-C70 and of 224 µM with NPM1-C53. These experiments indicate that 
both the presence of guanines at the hairpin loop and their number contribute, to 
the global affinity, suggesting that the 3D-structure of the G10-loop plays an 
important role. 
To further assess the DNA binding properties of NPM1, we next tested an 
oligo made only of T-bases (38-mer), hereby named poly-T (Fig. 3.1 B), and 
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measured a KD = 120 µM with NPM1-C70 and a KD = 520 µM with NPM1-
C53 (Table 3.1). This suggests that the increased flexibility of the polyT 
linear oligo with respect to the T10-loop can partly compensate for the 
absence of guanines. 
A further experiment was designed to establish the role played by guanines in 
a DNA sequence that does not necessarily form hairpin structures. We 
reasoned that if the protein preferentially recognizes with high affinity a 
hairpin loop made of guanines, it might also be able to induce such loop 
formation in a poly-G oligo and recognize it with good affinity (Figure 3.1 B). 
Thus with poly-G we expected to find a KD for NPM1-C70 higher than that 
found with the G10-loop but lower than that found with the poly-T oligo. 
Interestingly enough, with NPM1-C70 we obtained a KD = 5.8 µM, 
comparable to that of the physiological substrate G10-loop; with NPM1-C53 
we obtained instead a KD = 31 µM, the lowest measured so far with this 
protein construct (Table 3.1). These results suggest that the recognition of a 
poly-G oligo is far more specific than we might have anticipated. This may 
be rationalized by hypothesizing that this oligo is not linear but has the 
potential to form a structure that resembles that of the G10-loop. Indeed, by 
investigating the literature, we realized that a polyG oligo, if long enough, 
such as our 38-mer, has the potential to form 3D-structures known as G-
quadruplexes (Huppert and Balasubramanian, 2005; Neidle, 2009).  
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Ligand Analyte KD (µM) kon (M
-1
s
-1
) koff (s
-1
) 
G10-loop 
NPM1-C70 7.2 ± 0.2 2.8 ± 0.1 x 10
2
 
1.98 ± 0.03 x 
10
-3
 
NPM1-C53 169 ± 5 - - 
T10-loop 
NPM1-C70 307 ± 7 - - 
NPM1-C53 1170 ± 40 - - 
G5-loop 
NPM1-C70 40 ± 3 - - 
NPM1-C53 224 ± 6 - - 
Poly T 
NPM1-C70 120 ± 26 - - 
NPM1-C53 520 ± 30 - - 
Poly G 
NPM1-C70 5.8 ± 0.8 - - 
NPM1-C53 31 ± 4 - - 
cMyc  
NPM1-C70 1.9 ± 0.1 7.4 ± 0.3 x 10
3
 
1.37 ± 0.03 x 
10
-2
 
NPM1-C53 82 ± 15 - - 
Tab. 3.1 Dissociation constants and kinetic parameters as determined by SPR 
analysis 
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3.2 NPM1 C-terminal domain binds a sequence known to form a G-
quadruplex 
G-quadruplexes are formed by sequences displaying at least four stretches of 
at least three guanines, with no sequence requirements for the intervening 
loops that are usually one to seven nucleotides long (G3N1-7G3N1-7G3N1-7G3) 
(Huppert, 2008). The guanines interact with each other in an arrangement 
different from the classical B DNA pairing, forming planar tetraeds stabilized 
by the so-called Hoogsteen type H-bonds (Neidle, 2009; Huppert, 2008). These 
structures are greatly stabilized by Na
+
 or K
+
 ions that intercalate in the rings 
formed by the four guanines in the tetraed. Repetitive G-rich sequence 
stretches are highly represented in the human genome and are clustered at 
gene promoters, suggesting their functional importance.  
We decided to investigate whether one well-characterized G-quadruplex 
might interact with our NPM1 constructs. We focussed our attention on a 
sequence contained in the NHEIII (nuclease hypersensitive element III) region 
of the c-Myc promoter that is known to regulate up to 90% of total c-MYC 
expression. This is a well-characterized example of a parallel G-quadruplex 
forming region, both in vitro and in vivo (Gonzales et al., 2010). An oligo 
representing the G-quadruplex forming region of this promoter (hereby c-
MYC oligo) was therefore immobilized on a chip for SPR analysis (Fig. 3.1 
B). 
Interestingly, we found that NPM1-C70 binds the c-MYC quadruplex with a 
KD = 1.9 µM (Fig. 3.3 and Table 3.1), confirming that NPM1-C70 has high 
affinity for a sequence that adopts a G-quadruplex structure. Similarly to the 
31 
 
G10-loop, and contrary to the other oligos, both the association and 
dissociation rates could be calculated, suggesting that c-Myc G-quadruplex 
recognition is specific. Moreover, the experiment performed using NPM1-
C53 as the analyte led to a KD = 82 µM, confirming reduced affinity with this 
shorter domain (Fig. 3.3 and Table 3.1). 
                  
 
Fig. 3.3 SPR sensorgrams of the interaction between c-MYC and NPM1 
constructs. A) experimental curves (dashed lines with circles) represent different 
concentrations of NPM1-C70 used as the analyte and were fitted according to a 
single exponential binding model with 1:1 stoichiometry (continuous lines). B) 
experimental curves represent different concentrations of NPM1-C53. C) Scatchard 
plot referring to curves in panel B for dissociation constant determination. 
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3.3 The G10-loop forms a G-quadruplex structure in Vitro 
The results reported so far suggest that the NPM1 C-terminal domain 
recognizes with particularly high affinity sequences known to form G-
quadruplex three-dimensional arrangements. Under this light, it is interesting 
to note that the G10-loop sequence, which is predicted to form a hairpin 
according to conventional Watson-Crick pairing (Fig. 3.1B), also matches the 
above mentioned folding rule for G-quadruplexes and, accordingly, is 
predicted to form a G-quadruplex by the Quadparser algorithm (Huppert and 
Balasubramanian 2009). Therefore, when annealing, this oligo has the 
potential to form at least two alternative structures. To infer which of these 
two structures is the most likely to be populated, we first collected the CD 
spectra of G10-loop and c-MYC, for comparison. It is well known that 
circular dichroism is diagnostic of G-quadruplex formation (Huppert 2008). 
In particular, by comparing the spectra of the c-MYC oligo annealed in the 
absence or presence of 100mM NaCl or 100mM KCl, respectively, we 
observe a red-shift and increase in intensity of the peak at around 260 nm and 
the formation of a through at 240nm(Fig. 3.4A). Importantly the same 
features are observed in the case of the G10-loop spectra (Fig. 3.4B). These 
variations are both considered hallmarks of parallel G-quadruplex formation 
(Huppert 2008, Gonzàlez et al. 2009). A second indication of a G quadruplex 
structure for the G10-loop is derived from denaturation experiments. In Fig. 
3.4C the thermal melting profiles of G10-loop in the 25–105 °C interval are 
shown, whereas their corresponding static spectra are reported in Fig. 3.4D. 
These data indicate that the melting transition is still not complete at 105 °C 
for the G10-loop in the presence of 100mM KCl or NaCl, whereas a poorly 
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cooperative transition with a Tm centered at around 65–70 °C is observed 
when the same experiment is performed in the absence of monovalent 
cations. The predicted melting temperature for a G10-loop adopting hairpin 
structure is Tm =69.1 °C in 100 mM monovalent cations, according to the 
mfold server. Conversely the Quadpredict algorithm predicts higher Tm 
values, i.e. 94.9 and 77.1 °C, in the presence of 100 mM KCl or NaCl, 
respectively. These higher values are in better agreement with our 
experimental data, suggesting a G-quadruplex structure in these conditions. 
Thermal melting profiles were also collected for the c-MYC oligo (Fig. 
3.4E), as a control, and found to be similar to those obtained with the G10-
loop oligo (Fig. 3.4C).  
 
 
Fig. 3.4  G-10 loop adopts a G-Quadruplex fold in vitro. A, CD spectra of the c-
MYC oligo annealed in the absence (gray continuous line) or presence of 100 mM 
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NaCl (dashed line) or 100mM KCl (black continuous line), respectively. B, CD 
spectra of the G10-loop oligo. The line format is the same as in A. C, thermal 
denaturation profiles of G10-loop in the 25–105 °C interval and in the absence (gray 
continuous line) or presence of 100mM NaCl (dashed line) or 100mM KCl (black 
continuous line). D, CD spectra of the G10-loop in the absence (gray continuous, 
gray dashed dotted, and gray dotted at 25, 95, and 105 °C, respectively) or presence 
of 100 mM KCl (black continuous, black dashed dotted, and black dotted at 25, 95, 
and 105 °C, respectively). E, thermal denaturation profiles of c-MYC oligo in the 
25–105 °C interval, collected in the absence (gray continuous line) or presence of 
100mM NaCl (dashed line) or 100mM KCl (black continuous line). 
 
Finally we analyzed the binding of the porphyrin TmPyP4 to our oligos, by 
means of SPR. This molecule is known to bind G-quadruplex structures with 
high affinity and a complex stoichiometry involving at least two binding sites 
with different affinities (Freyer et al. 2007, Wei et al. 2006, Wei et al. 2010). 
The interaction of TmPyP4 with poly(T) oligo (Fig. 3.5A) determines a series 
of sensorgrams that, in the concentration range explored, always reach 
equilibrium before the end of the contact time between analyte and ligand, 
allowing both kinetic analysis, with a simple 1:1 model interaction (Fig. 
3.5A), and the construction of a Scatchard plot (Fig. 3.5B). The average value 
for this double determination is KD=345±15 nM and is compatible with the 
presence of a single binding site (Table 2). When analyzing the T10-loop 
data, again we observed a single binding site with a lower dissociation 
constant (KD=35±15 nM) (Fig. 3.5, C and D, and Table 2). Conversely, when 
analyzing TmPyP4 binding to the c-MYC oligo (Fig. 3.5, E and F) a more 
complex behavior was observed, depending on the TmPyP4 concentration. 
At low concentrations (bottom curves of Fig. 3.5E) the dissociation phase is 
characterized by a single process corresponding to the off-rate constant of a 
high affinity binding site. By increasing the TmPyP4 concentration, the off-
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rate becomes clearly biphasic (upper curves of Fig. 3.5E) reflecting the 
titration of a second binding site with lower affinity. 
Moreover, not all the traces reach the equilibrium, so that the corresponding 
Scatchard plot is determined for a subpopulation of the porphyrin 
concentrations studied. As a result, the equilibrium analysis performed via 
the Scatchard plot is not compatible with a single binding site (see the dashed 
line in Fig. 3.5F), whereas an excellent agreement is obtained assuming two 
independent  
 
Fig. 3.5 SPR sensorgrams of the interaction between the porphyrin TmPyP4 
and different oligos (panels A, C, E, and G for poly(T), T10-loop, c-MYC, and 
G10-loop, respectively) and their corresponding Scatchard plots (panels B,D, F, 
andH). A, poly(T), from bottom to top of the panel [TmPyP4]=1600, 800, 400, 200, 
100, 50, and 25 nM. Experimental data are reported as dashed lines with circles 
(where the concentration was measured twice, also as dashed line with squares); 
best fit assuming a 1:1 interaction is reported as a solid line. B, poly(T), Scatchard 
plot, open circles are experimental data points and the solid line is the fit assuming a 
single binding site. C, T10-loop, from bottom to top of the panel [TmPyP4]_1600, 
800, 400, 200, 100, 50, and 25 nM. Symbols used are the same as in panel A. D, 
T10-loop, Scatchard plot, the continuous line represents the best fit according to 1:1 
interaction model. E, c-MYC, from bottom to top of the panel [TmPyP4]=1600, 800, 
400, 200, 100, 50, 25, 12.5, 6.25, and 3.125 nM. Experimental data are reported as 
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solid lines. F, c-MYC, concentrations used in the Scatchard plot are 
[TmPyP4]=1600–25 nM. Open circles are experimental data points and the dashed 
line represents the best fit assuming a single binding site, whereas the solid line is 
the best fit assuming two independent binding sites. G, G10-loop, from bottom to 
top of the panel [TmPyP4]=1600, 800, 400, 200, 100, 62.5, 31.25, 25, and 15.625 
nM. Experimental data are reported as solid lines. H, G10-loop, the concentrations 
used in the Scatchard plot are [TmPyP4] =1600–31.25 nM. Symbols used are the 
same as in panel F. 
 
binding sites (solid line in Fig. 3.5F and see Table 3.2 for the corresponding 
KD values). Importantly, the experiments performed with the G10-loop 
indicated that TmPyP4 binding to this oligo follows the same behavior as 
observed with c-MYC, with the same stoichiometry and similar dissociation 
constants for the high and low affinity sites, respectively (Fig. 3.5, G and H, 
and Table 3.2). In conclusion, TmPyP4 binding data obtained with the G10-
loop are in agreement with those obtained with c-MYC and with previous 
work on G-quadruplex forming oligos (Freyer et al. 2007, Wei et al. 2006, 
Wei et al. 2010), whereas data obtained with the hairpin T10-loop are not. 
Taken together, our results suggest that, in the presence of physiological 
amounts of monovalent cations, the G10-loop folds as a G-quadruplex in 
vitro and might also have this structure when recognized in vivo by NPM1 
(Xu et al. 2007). 
 
 
Ligand KD (M) kon (M
-1
s
-1
) koff (s
-1
) 
Poly T  
330.9 ± 0.4 x 10
-9
 (Kinetics) 
1.013 ± 0.001 x 
10
8
 
33.52 ± 0.02  
360 ± 30 x 10
-9
 (Scatchard) - - 
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345 ±15 x 10
-9
 (Average 
value) 
  
T10-loop 
20 ± 10 x 10 
-9
 (Kinetics) 2.9 ± 0.8 x 10
10
 6.2 ± 2 x 10
2
 
50 ± 8 x 10
-9
 (Scatchard) - - 
35 ± 8 x 10
-9
(Average value)   
c-Myc  
Site 1: 8 ± 14 x 10 
-9
 - - 
Site 2: 1.3 ± 0.2 x 10 
-6
 - - 
G10-loop 
Site 1: 26 ± 3 x 10 
-9
 - - 
Site 2: 1.9 ± 0.9 x 10 
-6
 - - 
Tab. 3.2 Dissociation constants and kinetic parameters of TmPyP4 binding to 
selected DNA, determined by SPR analysis 
 
 
 
3.4 NPM1-C70 induces the Formation of G-quadruplex Structures 
Having established that NPM1-C70 binds with high affinity preformed G-
quadruplex structures, we next investigated whether it is able to induce G-
quadruplex formation in vitro. In Fig. 3.6A we report CD spectra of the not 
annealed c-MYC oligo titrated with NPM1-C70, in the absence of 
monovalent ions. By progressively increasing the amount of NPM1-C70 we 
observe, once again, a red-shift and increase in signal of the 260 nm peak and 
the progressive formation of a through at 240 nm, which indicates that a G-
quadruplex is formed upon protein binding. The same effect, albeit less 
evident, is obtained when using the G10-loop oligo (Fig. 3.6B). In a mirror 
experiment, using pre-annealed c-MYC or G10-loop oligos (Fig. 3.6, C and 
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D, respectively) we checked whether NPM1-C70 might have the property to 
destabilize pre-formed G-quadruplex structures. In both cases increasing 
amounts of protein had no effect on the CD signal of oligos pre-annealed in 
the presence of monovalent cations. Thus NPM1-C70 is able to induce G-
quadruplex formation in unstructured oligos, whereas it does not unwind pre-
structured oligos. 
 
 
Fig. 3.6 NPM1-C70 is able to promote the formation of G-quadruplex 
arrangement in unstructured oligos, whereas it does not unfold G-
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quadruplexes. A, not annealed c-MYC oligo (20µM) in the absence (gray solid 
line) and presence of increasing amounts of NPM1-C70 (gray dots, black dots, and 
black solid line for 10, 20, and 30 µM, respectively); the red shift and increase in 
amplitude at 260 nm and the formation of a through at 240 are indicative of G-
quadruplex formation. B, not annealed G10-loop oligo (20 µM) in the absence (gray 
solid line) or presence of increasing amounts of NPM1-C70 (gray dots, black dots, 
and black solid line for 70, 100, and 150 µM, respectively). C, spectra of c-MYC 
oligo (20 µM), pre-annealed in the presence of 100 mM NaCl, and incubated with 
increasing amounts of NPM1-C70 (same amounts as in panel A). D, same 
experiment as in panel C performed using the G10-loop (20 µM). Amounts of 
NPM1-C70 are the same as in panel B. 
 
 
 
3.5 Identification of key residues in the NPM1-quadruplex interaction 
Data reported so far strongly suggest that the NPM1 region comprised between 
the longer NPM1-C70 construct and the shorter NPM1-C53 construct (aa 
225-241) is necessary for high affinity binding. This region contains five 
lysine residues that we hypothesized might play a role in the specific 
recognition played by NPM1-C70 vs NPM1-C53 (Fig. 3.1). To test this 
hypothesis we mutated each of them into alanine. The K229A-K230A double 
mutant was also prepared. With these variant proteins we performed a 
complete set of SPR experiments to measure the binding affinities with the 
G10-loop and c-MYC oligos. Interestingly, none of the single mutants 
significantly affected the interaction when the variant proteins were tested 
against both oligos (Table 2.5). However, when testing the double mutant 
K229A-K230A, we observed a marked reduction in affinity and obtained a 
KD= 135 µM for the G10-loop and KD= 78 µM for the c-MYC oligo. These 
values are very close to those obtained when testing the two oligos with 
NPM1-C53 (compare Table 3.1 with Table 3.3) and suggest that residues 
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K229 and K230 cooperate to the specific and high affinity recognition played 
by NPM1-C70 on both oligos. Besides that, they also suggest that the mode 
of recognition of the c-MYC and G10-loop is likely to be similar, pointing 
again to a G-quadruplex structure for the G-loop oligo. 
 
 
Tab. 3.3 Dissociation constants and kinetic parameters of different NPM1-C70 
mutants binding as determined by SPR analysis  
 
 
 
 
 
 
G10-loop cMYC 
KD (µM) kon (M
-1s-1) koff (s
-1) KD (µM) kon (M
-1s-1) koff (s
-1) 
NPM-C70 
7.2 ± 0.2 2.8 ± 0.1 x 102 
1.98 ± 0.03 
x 10-3 
1.9 ± 0.1 7.4 ± 0.3 x 103 
1.37 ± 0.03 
x 10-2 
K229A 14.7 ± 0.8 1.6 ± 0.2 x 10
2 
2.30 ± 0.04 
x 10-3 
10.3 ± 0.9 7.3 ± 0.4 x102 
7.5 ± 0.3 
x10-3 
K230A 10.9 ± 0.3 
1.50 ± 0.02 x 
102 
1.60 ± 0.02 
x 10-3 
15 ± 1 2.8 ± 0.1 x102 
4.3 ± 0.1 
x10-3 
K233A 7.5 ± 0.5 4.5 ± 0.2 x 10
2 
3.4 ± 0.1 x 
10-3 
17.2 ± 0.6 3.0 ± 0.1 x102 
5.2 ± 0.1 
x10-3 
K236A 8.1 ± 0.2 3.3 ± 0.1 x 10
2 
2.70 ± 0.02 
x 10-3 
10 ± 1 2.8 ± 0.2 x102 
2.7 ± 0.2 
x10-2 
K239A 19.8 ± 0.5 
1.04 ± 0.02 x 
102 
2.05 ± 0.02 
x 10-3 
6.8 ± 0.9 8.7 ± 0.7 x102 
5.9 ± 0.3 
x10-3 
K229A-
K230A 
135 ± 8 - - 78 ± 7 - - 
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3.6 Structural characterization of NPM1 C-terminal binding domain 
By the experiments showed above we have investigated the NPM1 C-
terminal domain DNA binding activity trying to identify specific 
requirements for high affinity recognition both at the protein and DNA level. 
Our data suggest that the two protein constructs we analyzed, i.e. NPM1-C70 
and NPM1-C53, have a markedly different DNA binding activity. The 
shortest one, NPM1-C53, that was shown by Grummitt et al. to fold in a three 
helix bundle, is poorly competent for DNA binding, compared to the longest 
construct, NPM1-C70. Experimental evidence also suggests that NPM1-C70 
binds with high affinity specific DNA sequences that are able to fold in G-
Quadruplexes. This feature was initially characterized with a well-known a 
G-quadruplex forming region, both in vitro and in vivo, present in c-Myc 
promoter region (Gonzales et al., 2010) and later extended to the 
physiological NPM1 target found at the SOD2 promoter region used for 
initial experiments fold as a G-Quadruplex. Finally to definitively establish 
NPM1 as a bona fide G-quadruplex binding protein, we also showed that 
NPM1-C70 is able to induce G-quadruplex folding in the absence of 
stabilizing cations, and started to map residues important for G-quadruplex 
recognition in the N-terminal tail of the NPM1-C70 construct. 
Therefore NPM1 can be added to the increasing list of G-Quadruplex binding 
proteins. Even though the importance of G-quadruplex recognition for a 
variety of physiological processes is now clear, only very little structural 
information is available concerning the molecular recognition mechanism of 
complex formation (Sissi et al. 2011). To the best of our knowledge, only two 
structures are available: i) thrombin in complex with a synthetic aptamer that 
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folds as a G-quadruplex (Padmanabhan et al. 1993), and ii) the Oxytricha 
nova TEBP heterodimer bound to its telomeric sequence (Horvath et al. 
2001). 
Therefore we decided to analyze the interaction of NPM1 DNA binding 
domain with the G-quadruplex sequence from the NHEIII region of the c-
MYC promoter, using NMR techniques. This work was performed in 
collaboration with Prof. Ivano Bertini and Prof. Lucia Banci, at CERM 
laboratories, University of Florence. 
For NMR experiments we used the NPM1-C70 protein construct, having 
previously shown that the shorter NPM1-C53 is poorly competent for DNA 
binding and that the 17-residue lysine-rich region at its N-terminus (residues 
225-241) that differentiate NPM1-C70 from NPM-C53 is necessary for high 
affinity. 
As a first step we determined, by a combination of standard NMR techniques, 
the structure of NPM1-C70, since only the structure of NPM1-C53 was 
known (Grummitt et al., 2008). The protocol used for structure determination 
is detailed in the Materials and Methods section while statistics about 
structure determination are shown in Table 3.4.  
The structure depicted in Figure 3.7A comprises a well-defined 3-helix 
bundle, similar to the NPM1-C53 construct (Grummitt et al. 2008), in terms 
of length, relative orientation and hydrophobic interactions between all the 
helices in pair (Fig. 3.7A). On the other hand, the lysine-rich region (residues 
225-241) that enhances DNA binding is unstructured, as indicated by high 
values of 15N-1H R1 (Fig. 3.7B) and low values for 15N-1H R2 (Fig. 3.7C) and 
heteronuclear NOEs (Fig. 3.7D), with no secondary structure elements, nor 
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any propensity to fractionally take them as clearly shown from the chemical 
shift index analysis (Fig. 3.7B-C). Conversely, the folded part of the NPM1-
C70 construct shows 15N-1H R1 and 15N-1H R2 values typical of an 8 kDa 
protein (Fig. 3.7B-C) and positive values for heteronuclear 15N{1H} NOEs 
values (Fig. 3.7D), even though the latter are lower than those of a rigid 
protein, thus indicating the occurrence of fast internal motions. 
 
 
Fig. 3.7 NPM1-C70 quadruplex-binding C-terminal domain, encompassing 
residues 225-294. A) NMR solution structure of NPM1-C70 showing the twenty 
lower-energy structures. A lysine-rich natively unstructured segment (aa 225-242) 
precedes the terminal three-helix bundle. B) 
15
N-
1
H R1 NOE values and C) 
15
N-
1
H 
R2 NOE values. Low R1 and high R2 values for segment 225-242 are consistent with 
the N-terminal tail being unstructured. D) Heteronuclear 
15
N{
1
H} NOEs are positive 
but smaller than expected for a 8 kDa protein, indicating fast internal motion in the 
three-helix bundle. Red lines indicate average values for the 225-242 and the 243-
294 segments, respectively. 
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Table 3.4 Statistical analysis of the energy minimized family of conformers of 
NPM1-C70  
 
 
3.7 The complex of NPM1-C70 with c-MYC G-quadruplex DNA 
We have already shown that NPM1-C70 binds a DNA oligonucleotide 
resembling a specific sequence found at the NHEIII region of the c-MYC 
promoter and that this 27-mer region (c-MYC Pu27) of sequence, 5’-
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TGGGGAGGGTGGGGAGGGTGGGGAAGG-3’, is known to form a 
parallel G quadruplex structure in the presence of K+ at physiological 
concentration (100- 150 mM) (Gonzàlez and Hurley 2010). Pu27 contains 
five runs of three or more consecutive guanines and therefore can, in 
principle, populate several G-quadruplex structures with different topologies 
(Huppert 2008). These multiple conformations are indeed observed in the 
free state, as monitored by multiple sets of NMR signals in slow exchange in 
the 1D 1H NMR spectra (Fig. 3.8A, blue line). Moreover, Pu27 maintains 
different G-quadruplex topologies also when bound to NPM1-C70 (Fig. 
3.8A, red line). The structural heterogeneity of the Pu27 sample complicates 
the analysis of its interaction with NPM1-C70.  
However, recently, Patel and coworkers showed that a c-MYC derived shorter 
oligonucleotide of 24 residues, containing a guanine to inosine substitution in 
one of the guanine runs, populates only one of the possible G-Quadruplex 
conformations (called Pu24I: 5’-TGAGGGTGGIGAGGGTGGGGAAGG-
3’) (Phan et al. 2005). Therefore we decided to use this oligonucleotide for 
further studies that were greatly facilitated by the availability of the 1H nuclei 
assignment for the Pu24I oligonucleotide, gently provided to us by courtesy 
of Anh Tuan Phan and Vitaly Kuryavyi (Phan et al. 2005).  
 First, by comparing the 1D 1H NMR spectra of Pu24I in the free state 
and bound to NPM1-C70, we confirmed that Pu24I, differently from Pu27, 
displays only a single G-quadruplex topology that is retained after NPM1-
C70 binding (Fig 3.8B). Then, to assess whether Pu24I undergoes major 
conformational changes upon NPM1-C70 binding, we performed 
intramolecular NOEs experiments for the bound state of Pu24I and compared 
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it to its free state. To characterize the bound state a ω1 13C-filtered, ω2-13C-
filtered NOESY experiment was recorded in a 2D plane (1H-1H plane) while, 
in the case of Pu24I free state, a standard 2D NOESY was performed. As 
shown in Figure 3.8C, no major variations are visible in the superimposition 
of the two spectra, indicating that the G-quadruplex structure of Pu24I is 
maintaining its conformation when bound to NPM1-C70. 
  
              
Fig. 3.8 Analysis of Pu27 and Pu24I G-quadruplex conformations. A) 
Superimposition of the 1D 
1
H NMR spectra of Pu27 in the free state (blue) and 
bound (red) to C70-NPM1. Both spectra were acquired at 700MHz and at 290K. B) 
Superimposition of the 1D 
1
H NMR spectra of Pu24I in the free state (blue) and 
bound (red) to C70-NPM1. Both spectra were acquired at 700MHz and 290K. C) 
Details of the superimposition between ω1-
13
C-filtered, ω2-
13
C-filtered NOESY 
experiments in a 2D plane (
1
H-
1
H plane) of Pu24I-NPM1-C70 complex (black) and 
a classical 2D NOESY of Pu24I in its free state (red). Both spectra were acquired at 
700 MHz and 290K. 
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To further investigate the interaction of NPM1-C70 with Pu24I, we titrated 
15
N-labeled NPM1-C70 with increasing amounts of unlabeled Pu24I, 
following  
1
H-
15
N HSQC spectra of labeled NPM1-C70. (Fig. 3.9). 
 
 
Fig. 3.9 
1
H-
15
N HSQC spectra of 
15
N-labeled NPM1-C70. 
1
H-
15
N HSQC spectra 
of labeled NPM1-C70 before (green) and after addition of unlabeled Pu24I, 
respectively 50% (red) and 100% (blue) of NPM1-C70 concentration. Spectra were 
acquired at 700MHz and 290K. 
 
The NMR titration results confirm the interaction between the NPM1-C70 
and Pu24I and, by analyzing  
1
H-
15
N HSQC spectra, we observed both the 
appearance of new peaks and the disappearance of others, indicating the 
formation of a new species that exchanges slowly with the free protein on the 
NMR time scale, i.e. < 10
-2
 s
-1
 (Fig. 3.9 and 3.10A). The ratio of the intensity 
of the signals, for a given resonance in the two species, changes linearly with 
48 
 
the amount of Pu24I, and reaches a plateau upon addition of stoichiometric 
amounts of Pu24I, consistently with a 1:1 protein- Pu24I complex (Fig. 3.9). 
In particular some signals of the  protein experience a significant change in 
chemical shift (δHN). To define which residues are interacting residue the 
CSP (Chemical Shifts Perturbation) should be higher than the average 
variations plus one standard deviation  (<δHN> = 0.043 ± 0.025 ppm, Black 
line in Fig. 3.10B). Also signals that broaden their linewidth or disappear 
during the titration were taken under consideration. 
This analysis shows that NPM1-C70 interacts with Pu24I mainly via 
hydrophilic residues, located in helices H1 and H2 and exposed on the same 
side of the protein (Fig. 3.10B and Fig 3.10C). Interestingly, also a few 
residues located on helix Η3 display chemical shifts variations (Fig. 3.10B 
and Fig. 3.10C). Since the latter are buried and interact with helices Η1 and 
Η2, we conclude that a strong coupling is present among the 3 helices. In the 
protein-Pu24I complex, no chemical shift variations are detected for residues 
belonging to the NPM1-C70 N-terminal unstructured segment, indicating that 
this tail is not directly involved in the complex (Fig. 3.10B). This surprising 
result is confirmed by analysis of the 15N-heteronuclear relaxation data in the 
complex, where the N-terminal tail is still characterized by high values for 
heteronuclear 15N-1H R1 (Fig. 3.10D) and low values for heteronuclear 15N-1H 
R2 (Fig. 3.10E) and heteronuclear NOEs (Fig. 3.10F), consistent with a 
natively unstructured state. Conversely, the folded C-terminal region of 
NPM1-C70 shows 15N-1H R1 and 15N-1H R2 values typical of a complex of 16 
kDa molecular weight (in agreement with the sum of the molecular weights 
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of NPM1-C70 and Pu24I) and positive values for heteronuclear 15N{1H} 
NOE values (Fig. 3.10E-D-F). 
Both results suggest that the complex between NPM1-C70 and Pu24I is 
stable, consistent with the high affinity described in previous observation for 
the Pu27 oligonucleotide. The relaxation data analysis also pointed out that 
the heteronuclear 15N{1H} NOE values increase in the folded region of 
NPM1-C70, indicating an increasing rigidity for the three-helix bundle of 
NPM1-C70 upon binding of Pu24I (Fig. 3.10F). 
 
 
Fig. 3.10 Interaction of NPM1-C70 with the Pu24I G-quadruplex. A) 
15
N HSQC 
spectra of the protein before (black) and after addition of stoichiometric amounts of 
unlabeled Pu24I (red). Representative chemical shift variations are labeled 
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indicating relevant residues. B) Chemical shift variations cluster in the three-helix 
bundle while they are not found at the N-terminal 225-242 segment. The horizontal 
black line indicates the average chemical shift variation plus one standard deviation 
upon Pu24I addition. C) Residues experiencing chemical shift variations higher than 
the average plus one standard deviation are highlighted on the structure of the 
protein. Residues belonging to helices H1 and H2 are solvent exposed. A few 
hydrophobic residues belonging to helix H3 are also affected indicating coupling 
between the helices upon Pu24I binding. D) Heteronuclear 15N-1H R1 and E) 
heteronuclear 15N-1H R2 values for NPM1-C70 in complex with Pu24I indicate 
that the N-terminal region flanking the three-helix bundle remains unstructured after 
Pu24I binding. F) The increase of heteronuclear 15N{1H} NOE values in the three 
helixbundle upon Pu24I binding (see Figure 3.7D for comparison) suggests increate 
rigidity. 
 
 
 
3.8 Experimentally restrained molecular docking of the NPM1-C70 – 
Pu24I complex 
To gain additional information on the structure of the complex, 
13
C-filtered 
NOESY experiments were performed. Six intermolecular NOEs were 
detected between NPM1-C70 and Pu24I in the complex (Table 3.5). An 
example of assignment of NOE cross-peaks is shown in Figure 3.11A. They 
involve Lys and Asn residues of the protein (whose sidechains are let free to 
rotate during the subsequent docking calculation) and sugar backbone 
protons on Pu24I. These distance restraints, together with the chemical shifts 
perturbations defined as Ambiguous Interaction Restraints (AIRs; also listed 
in Table 3.5), were used to calculate a structural model of the NPM1-
C70/Pu24I complex, within the data-driven HADDOCK docking program 
(see the Experimental section for details about the protocol used).  
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Table 3.5 Intermolecular NOEs and AIRs used for HADDOCK docking 
calculations 
 
 
Importantly, HADDOCK calculations identified a single cluster of docking 
poses. In particular, 184 final complex structures were obtained at the end of 
the procedure with a RMSD from the lowest energy solution of 1.5 + 0.9 Å. 
As an example, the twentieth lower Energy docking poses are reported in 
Figure 3.11B. As shown in Figure 3.11C the interaction surface involves one 
side of the three-helix bundle, the interacting residues being all located on 
helices H1 and H2, with a buried area of 1358.6 +/- 92.2 Å2. Based on the 
assignment of the intermolecular NOEs (Figure 3.11A and Table 3.5), the 
interaction involves side chains of NPM1-C70 residues Lys250, Lys257, 
Asn270 and Asn274. On the Pu24I side, intermolecular NOEs indicate the 
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involvement of protons of the backbone (mainly the deoxyribose ring) of 
nucleotides T1, G11, A12, G13, G15 and G23. From the structure model 
analysis, a linear stretch of nucleotides (from G11 to G16) located on one 
side of  
   
Fig. 3.11 Intermolecular NOEs and HADDOCK calculations and structural 
model of the NPM1-C70/Pu24I complex. A) An example of NOE cross peaks 
assignment from ω1-
13
C-edited, ω2-
13
C-filtered NOESY experiments in a 2D plane 
(1H-1H plane) of the NPM1-C70-Pu24I complex acquired on a 
13
C,
15
N NPM1- 
C70/unlabeled Pu24I sample. B) The twentieth lower energy complex structures 
obtained by NMR-data restrained molecular docking calculations using the 
HADDOCK protocol. NPM1-C70 is represented in blue and Pu24I in green. C) 
Ribbon representation of the lowest energy model, showing helices H1 and H2 of 
NPM1-C70 approaching the G-quadruplex “laterally” and interacting with a specific 
segment of the backbone (in orange). D) NPM1-C70 is represented with its 
electrostatic surface (blue for positive and red for negative, respectively), while 
Pu24I is in ribbon. The Pu24I structure is shown in transparency to highlight the 
small positively charged groove in between helices H1 and H2 that accommodates a 
stretch of Pu24I nucleotides (G11-G16, colored in orange). The long unstructured 
tail is also positively charged and may play a role in long range electrostatic 
interactions with the approaching oligonucleotide. 
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 the G-quadruplex scaffold (Fig 3.11C), intercalates into a groove formed by 
helices H1 and H2 (Fig. 3.11D). Interestingly, this stretch contributes to the 
formation of each of the three stacked guanine tetrads in the G-quadruplex 
scaffold. By analyzing the twentieth lower energy docking solutions it 
appears that residues Lys250, Lys257, Asn270 and Asn274 always 
participate to the formation of salt bridges or hydrogen bonds with backbone 
phosphates belonging to the G11-G16 linear stretch. In addition, residues 
Lys267 and Cys275 are always found at the interface, where they contact 
phosphate groups in the G11-G16 stretch, in all twentieth lower energy 
docking poses. 
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4 Discussion 
The initial aim of this work was to better understand the DNA binding 
features of NPM1, starting from foundations already established by others, 
that described the NPM1 C-terminal domain as responsible of DNA binding 
with a increased affinity for single-stranded structures over duplexes and no 
sequence requirements (Wang et al. 1989, Dumbar et al. 1994). 
Since binding experiments reported so far were rather qualitative, we resorted 
to develop binding assays with the Surface Plasmon Resonance (SPR) 
technology in order to quantitatively describe the NPM1-DNA binding 
reaction. 
Our first SPR experiments indicate that, besides the shorter NPM1-C53 
construct being able to recognize any oligonucleotide tested with low 
affinity, high affinity recognition is achieved only with NPM1-C70, thus 
establishing that the lysine rich tail located at the N-terminus of the C-
terminal three-helix bundle of the protein plays a role in DNA recognition 
(Hingonari et al., 2000). 
Moreover, rather than just being a single stranded binding protein as initially 
suggested, NPM1’s preferential binding is for oligonucleotides with defined 
3D structure. Indeed this is the case of the G10-loop, a sequence found at the 
promoter of the SOD2 gene, which is bound by NPM1 in vivo and was 
predicted to form a hairpin based on conventional Watson-Crick pairing (Xu 
et al., 2007). 
However, a predicted hairpin structure is not sufficient to confer high binding 
affinity, as shown by the results obtained with an alternative oligonucleotide, 
(T-10 loop), or modifying the oligonucleotide in the hairpin by reducing the 
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number of guanines in the loop (G-5 loop). We showed that  in both cases 
affinity is reduced (Fig. 3.1, Tab. 3.1). These experiments suggest that both 
the presence of guanines and their number (table 3.1) in the loop contribute to 
the global affinity, indicating that the 3D structure adopted by the G-10 loop 
oligo plays a critical role in recognition. 
 Further investigations suggested that not only the predicted hairpin 
structure of the G10-loop is not per se sufficient to confer protein high 
affinity recognition but also indicated that the expected hairpin might not be 
the real structure adopted by the G10-loop in vitro and possibly also in vivo. 
First, we showed that NPM1-C70 is able to recognize with high affinity 
oligos characterized by G-rich sequences, and specifically those obeying the 
G-Quadruplex folding rule (Huppert and Balasumbramanian 2005). This was 
shown first using a poly(G) oligo of the same length of the G-10 loop and, 
importantly, further confirmed with the well-characterized G-Quadruplex 
forming sequence located at the Nuclease Hypersensitive Element IIIi 
(NHEIII1) of the c-MYC promoter (Pu27), a 27-mer region that is known to 
adopt a G-quadruplex conformation both in vitro and in vivo.  
Since the G-10 loop sequence obeys itself to the G-quadruplex folding rule, 
we started investigating whether this might be the real structure adopted by 
the oligonucleotide.  
First, CD spectroscopy shows that the G10-loop presents all the hallmarks of 
parallel G-Quadruplex formation in the presence of physiological 
concentrations of K
+
 or Na
+
 ions. Moreover we found that the thermal 
unfolding of this oligo in the presence of monovalent cations is still not 
complete at temperatures as high as 105°C, reflecting the enhanced stability 
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conferred to G-Quadruplex structures by K
+
 and Na
+
. Finally we showed that 
the G10-loop, contrary to the T10-loop, is capable of binding the porphyrin 
TmPyP4 with the same stoichiometry and similar dissociation constants of 
the Pu27 c-MYC oligo, behaving as expected for a G-Quadruplex forming 
oligo. 
Taken together, these data strongly suggest that the G10-loop is indeed 
folded as a G-Quadruplex in vitro. Moreover they suggest that NPM1 rather 
that recognizing specific sequences, shows a preference for specific 3D 
structures and in particular for G-quadruplexes. This was further confirmed 
by experiments showing that NPM1-C70, besides binding G-quadruplex 
forming regions, is also capable of promoting G-quadruplex formation in 
vitro. This property may be relevant for NPM1 regulatory functions in the 
cell and needs to be further investigated, especially in light of a putative more 
general role of the protein, than originally expected, in transcriptional 
regulation. For instance, it was shown that NPM1, through its interaction 
with the G-10 loop, promotes the transcriptional activation of the SOD2 gene 
(Xu et al. 2007) and it is thus possible to hypothesize that other genes, 
containing G-quadruplexes in their promoter genes, might be regulated by 
NPM1. 
Under this light it is interesting to note that a large number of promoter 
regions have been investigated and shown to contain regions capable of 
forming fully folded G-Quadruplexes at least in vitro (Qin and Hurley 2008). 
In particular these regions are frequently associated to oncogene promoters 
while they are generally absent in tumor suppressor genes promoters. This 
association of G-Quadruplex with gene promoters was consistent with the 
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hypothesis of linking G-Quadruplexes formation with transcriptional control 
of genes (Simonson et al. 1998).  
 One of the best characterized G-Quadruplex regulating activity is 
represented by the NHEIII1 region at the c-MYC promoter, that is able to 
suppress up to 90% of c-MYC gene in vivo transcription when adopting a G-
Quadruplex structure, thus inhibiting tumor growth in xenograft tumor mouse 
models (Grand et al. 2002). In other cases G-quadruplex stabilization may be 
associated to gene activation, possibly through protein binding (Huppert 
2008), as already shown for the SOD2 promoter (Xu et al. 2007).  
 The selective localization at oncogene promoters and telomeres makes 
of G-quadruplex DNA an attractive target for tumor treatment, and the 
structures of several G-quadruplex regions alone and in complex with drugs 
have been reported (Neidle 2009). Conversely, although the list of proteins 
that bind G-quadruplex DNA is rapidly increasing and the importance of 
such interactions for a variety of physiological processes is now clear, very 
little structural information is available concerning the molecular recognition 
mechanism (Sissi et al. 2011). To the best of our knowledge, only two 
structures are available: (i) thrombin in complex with a synthetic aptamer that 
folds as a G-quadruplex (Padmanabhan et al. 1993) and (ii) the Oxytricha 
nova telomere-binding protein heterodimer bound to its telomeric sequence 
(Horvath et al. 2001). 
 Thus, in the second part of my Ph.D. work, we decided to characterize 
the NPM1-G-quadruplex interaction from a structural point of view, both 
because such data could shed new light on the roles played by NPM1 in the 
cell that are lost in the leukemic blasts, and also, more in general, because 
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they would contribute to better understand protein-G-quadruplex interaction 
properties. Among the several oligonucleotides tested, we focused our 
attention on the interaction of NPM1-C70 with the G-quadruplex at the 
NHEIII region of the c-MYC promoter, because this is the DNA sequence 
bound with the highest affinity whose structure is known (Linge et al. 2003). 
 The structure of NPM1-C70 alone and bound to the DNA fragment 
was investigated by a combination of NMR experiments and docking 
calculations guided by experimental restraints. As shown in Figure 3.11, 
NPM1-C70 binds the Pu24I G-Quadruplex through a specific surface at the 
interface between helices H1 and H2. Several positively charged and polar 
residues establish interactions mainly with phosphate groups of a linear 
stretch of nucleotides, which fits the small groove at the H1-H2 interface. 
Interestingly, this stretch contributes to the formation of the main G-
Quadruplex scaffold while the interactions with nucleotides belonging to the 
connecting loops appear marginal. This may explain why NPM1 recognizes, 
with comparable affinity, several G-Quadruplexes, which differ in loop 
length and distribution. 
 Analyzing NPM1-C70 residues involved in the interaction, much 
interest was generated by Lys257 and Lys267, because they are acetylated in 
vivo by p300 and deacetylated by SIRT1 (Shandilya et al. 2009). NPM1 
acetylation results in dislocation of the protein from nucleoli to the 
nucleoplasm, where NPM1 interacts with transcriptionally active RNA 
Polimerase II. Our finding that these two residues are at the interface with 
Pu24I DNA suggests that loss of nucleolar localization may be due to 
impaired DNA binding at the nucleoli coupled to acetylation. 
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Interestingly, we also found from docking simulations that Cys275 is always 
located at the center of the surface buried by Pu24I. Cys275 is targeted and 
alkylated by the natural antitumoral compound (+)-avrainvillamide (Wulf et 
al. 2007). Treatment of LNCaP or T-47D cells with (+)-avrainvillamide leads 
to an increase in cellular p53 concentrations and promotes apoptosis. It is 
therefore conceivable that these effects may be linked to (+) avrainvillamide 
mediated impairment of NPM1 nucleic acid binding efficiency. 
When we investigated the structure of NPM1-C70, both alone and in 
complex with the c-MYC quadruplex, we were particularly interested in 
analyzing the arrangement of the N-terminal tail of NPM1-C70 construct, the 
lysine-rich 17-residue region that differentiate NPM1-C70 from NPM1-C53. 
Indeed we had previously shown that this region is i) required for high 
affinity binding and ii) does not form any particular secondary structure 
element, neither before nor after binding. To our surprise we showed that this 
region is completely unstructured both before binding and in complex with 
Pu24I and, more importantly, it does not contribute to the final complex. 
By inspecting the literature, however, we realized that this finding parallels 
previous observations in other systems. For instance, the affinity of the 
cAMP- responsive element-binding protein KID domain for the KIX domain 
of the cAMP-responsive element-binding protein- binding protein is 
significantly reduced when an unstructured portion of the domain that does 
not participate directly to the complex contact surface is deleted (Zor et al. 
2002). Similarly, the interaction of splicing factor 1 with the large subunit of 
the U2 small nuclear RNA auxiliary factor (U2AF65) is affected by flanking 
unstructured regions that do not physically contact the partner (Selenko et al. 
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2003). This phenomenon, which is more frequent than previously anticipated, 
has been termed “flanking fuzziness” (Tompa and Fuxreiter 2008). 
Furthermore, it was shown recently that a large fraction of transcription 
factors are characterized by the presence of unstructured regions that flank 
the DNA-binding domain, at one or both ends, and that these regions may 
impact the affinity for specific or nonspecific DNA sequences (Gao et al. 
2012). 
What could the role of this unstructured N-terminal tail of NPM1-C70 be? 
Although this issue is still under investigation, it is conceivable that the 
presence of an unstructured segment adjacent to the interacting domain may 
provide a larger platform for long range electrostatic interactions or even 
transient physical contacts that facilitate the fine tuning of binding (Tompa 
and Fuxreiter 2008). This is supported by our observation that two 
concomitant Lys to Ala substitutions (Lys229-Lys230) in the unstructured 
segment of NPM1-C70 result in a dramatic decrease of global affinity. 
Furthermore, exposed unstructured regions may be modified by post-
translational modifications, driving regulatory changes. Several residues in 
the unstructured segment may be modified, such as Lys229 and Lys230 that 
are among the lysines acetylated by p300 and deacetylated by SIRT1 
(Shandilya et al. 2009). A number of putative phosphorylation sites are also 
present in the tail, including Ser227, Thr234, Thr237, and Ser242; among 
these, the phosphorylations of Ser227 by PKC and of Thr234-Thr237 by the 
Cdk1-cyclinB complex were experimentally validated (Beckmann et al. 
1992, Okuwaki et al. 2002). Both acetylation and phosphorylation may 
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therefore interfere with NPM1 nucleic acid binding and play a role in NPM1 
activ- ity and trafficking throughout the cell cycle. 
In conclusion, in this work we have undertaken a rigorous analysis of the 
DNA binding activity of the NPM1 C-terminal domain, which is largely 
destabilized in Acute Mieloyd Leukemia patients bearing mutations at the 
NPM1 gene. We initially focused on defining both the domain boundaries 
necessary for high affinity recognition and on the DNA sequences and 
structures that could be recognized efficiently. These studies led to the 
identification of NPM1 as a novel G-quadruplex binding protein. Then we 
analyzed the structure of NPM1 C-terminal domain in complex with a 
representative G-quadruplex and i) identified residues directly involved in the 
binding, and ii) provided a structural explanation for the higher affinity 
displayed by NPM1 for G-quadruplex sequences.  
Leukemia-associated NPM1 mutations cause dramatic destabilization up to 
total unfolding of the terminal three-helix bundle that is responsible for the 
aberrant cytosolic transloca- tion of the protein. Scaloni et al. (Scaloni et al. 
2009, Scaloni et al. 2010) showed that a malleable “native-like” structure that 
accelerates folding is retained in the denatured state of the wild-type NPM1-
C53 three-helix bundle and involves helices H2 and H3 (H3 is also the site of 
leukemic mutations), whereas helix H1 is totally unfolded in the denatured 
state. A possible strategy to rationally target NPM1 for the treatment of this 
type of leukemia might be that of developing a drug able to stabilize in the 
leukemic variant a native-like structure by altering through binding the 
folding-unfolding equilibrium in favor of the native state. Our folding studies 
suggested that such a drug should preferentially target helix H1. Because we 
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have shown here that G-Quadruplex DNA specifically binds a region in 
between helices H1 and H2 of NPM1- C70, we may attempt to rationally 
design aptamers or other smaller molecules that by mimicking the binding 
properties of G-quadruplexes to NPM1 C-terminal domain might stabilize a 
native-like state in the leukemic variant. 
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5 Experimental Procedures and Methods 
 
5.1 Cloning and expression of Cter-NPM1 construct: NPM1-C53 and 
NPM1-C70. 
NPM1-C53 (Nucleophosmin ∆N-242) gene was obtained by gene synthesis 
(GeneART, Ragensburg, Germany) and was cloned into a pET28+(a) vector 
(Novagen, San Diego, CA) between restriction sites NdeI and BamHI (New 
England Biolabs, Hitchin, UK). 
NPM1-C70 (Nucleophosmin ∆N-225) gene was obtained by gene synthesis 
(GeneART, Ragensburg, Germany) and was cloned into a pET28+(a) vector 
(Novagen, San Diego, CA, USA) between restriction sites NdeI and BamHI 
(New England Biolabs, Hitchin, UK). 
Both protein construct were expressed fused to thrombin cleavable His6-tag at 
N-terminus, using E.coli BL21(DE3) strain as expression system. 
Expression of NPM1-C53 and NPM1-C70 is similar and provide transformed 
cells growth  A600=0.5 in LB medium supplemented with Kanamycin at 37 °C. 
At this point 1mM isopropyl 1-thio-β-D-galactopyranoside (Inalco, Milan, Italy) 
was added and cells were further grown at 20 °C for 16 h under vigorous flask 
shaking. 
 
5.2 Protein purification. 
Also purification protocols of NPM1-C53 and NPM1-C70 are similar and begin 
with cells harvesting and resuspending in lysis buffer (Hepes 20 mM pH 7.0, 
150 mM NaCl, 25 mM Imidazole, 5 mM β-mercaptoethanol). Cells were 
supplied with a protease-inhibitor cocktail (Roche, Basel, Swiss). 
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Sonicated cells were centrifuged and supernatants were recovered.  
Proteins were purified using a 5ml Ni
2+
 chelating affinity column (GE-
Healthcare, Boston, USA) loaded at 1 ml/min and washed with three column 
volumes with lysis buffer. Elutions were performed with a linear gradient 
from 0 to 100% elution buffer (Hepes 20 mM pH 7.0, 150 mM NaCl, 1 M 
Imidazole, 5 mM β-mercaptoethanol) with a flow rate of 2 ml/min. Peak 
fractions were pooled and fractions containing the protein, as judged from 
SDS-PAGE, were collected, diluted 10-fold with lysis buffer, and incubated 
with thrombin . 
The fusion proteins were cleaved by thrombin digestion with 1 U enzyme per 
2 mg fusion protein, at 4°C for 2h.  
After thrombin cleavage the reaction mixture was supplemented with 
protease inhibitors (Roche Applied Science) and loaded on a Ni
2+
 affinity 
column, pre-equilibrated with lysis buffer, to remove the thrombin clave N-
terminal His tag and uncleaved protein. Protein was recovered from the flow-
through, diluted 10-fold with 20mM Hepes, pH 7.0, 5 mM β-
mercaptoethanol, and loaded on a SP-Sepharose column pre-equilibrated 
with the same buffer. Protein was eluted using a NaCl linear gradient, from 0 
to 100% elution buffer (Hepes 20 mM pH 7.0, 1 M NaCl, 5 mM β-
mercaptoethanol) with a flow rate of 2 ml/min. Peak fractions were pooled 
and buffer was exchanged to remove the salt, concentrated up to 600mM, 
with 20 mM Hepes buffer, pH 7.0, 5mM β-mercaptoethanol, by using 
concentration tubes with cut-off of 3000 Da according to the manufacturer 
instructions (Millipore, Billerica, MA, USA), and stored at -20 °C. 
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For isotope enrichment of protein sample, cells were grown in a minimal 
medium with (
15
NH4)2SO4 and [
13
C]glucose, using same unlabeled protocol 
both for expression and purification. 
 
5.3 Site-direct mutagenesis 
NPM1-C70 protein variants were obtained through site-directed mutagenesis 
and using the QuikChange II kit (Stratagene, La Jolla, CA), following the 
manufacturer’s instructions. Forward oligos used for PCR are the following: 
 K229A,  
5’ 
CATATGCAGGAAAGCTTCGCGAAACAGGAAAAAACGCCGAAAAC
C- 3’;  
K230A, 5’- 
ATATGCAGGAAAGCTTCAAAGCGCAGGAAAAAACGCCGAAAACC
- 3’; 
 K229A/ K230A, 5’-
CATATGCAGGAAAGCTTCGCGGCGCAGGAAAAAACGCCGAAAAC
CCCGAAAGGCCCG- 3’;  
K233A, 5’-CAGGAAAAAACGCCGGCGACCCCGAAAGGCCCGAGC- 
3’; 
K236A, 5’-CCGAAAACCCCGGCGGGCCCGAGCAGCGTG-3’; 
 and  
66 
 
K239A,  
5’-
GAAAGCTTCAAAAAACAGGAAGCGACGCCGAAAACCCCGAAAGG
C-3’.  
NPM1-C70 protein variants were expressed and purified as the wild-type 
construct. 
 
5.4 Oligonucleotides 
Oligonucleotides used (Fig.3.1B) were purchased from PRIMM s.r.l (Milan, 
Italy) and purified by HPLC. Oligonucleotides used for SPR analysis were 
biotinylated at the 5’-end. Prior to use, lyophilized oligos were resuspended 
in the appropriate buffer (20 mM Hepes, pH 7.0, with or without 100mM 
NaCl or KCl (according to the different experiments), quantified 
spectrophotometrically and annealed. For annealing, oligos were heated to 95 
°C for 15 min and slowly cooled down at RT, overnight. 
Oligonucleotides used in NMR experiments studies are Pu27 of sequence 5’- 
TGGGGAGGGTGGGGAGGGTGGGGAAGG-3’ and Pu24I of sequence 
5’- TGAGGGTGGIGAGGGTGGGGAAG G-3’. Pu27 and Pu24I were 
purchased from PRIMM (Milano, Italy) and from IDT (San Jose, CA), 
respectively, and were both HPLC-purified. Lyophilized oligos were 
dissolved in Phosphate buffer 20 mM pH 7.0, KCl 100 mM and annealed, as 
described for other Oligos.  
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The parallel G-quadruplex assembly of both oligos, after annealing, was 
assessed by inspecting CD spectra collected with a Jasco J-710 
spectropolarimeter. 
 
5.5 Surface Plasmon Resonance  
The interactions between biotynilated DNA constructs (ligands) with the purified 
proteins NPM1-C70 or NPM1-C53 (analytes), were all measured by SPR 
technique using a Biacore X100 instrument (Biacore, Uppsala, Sweden). Each 
biotynilated DNA construct was immobilized on a Sensor Chip SA, pre-coated 
with streptavidin from Biacore AB (Uppsala, Sweden). Capturing procedure on 
biosensor surface was performed according to manufacturer’s instructions and 
setting the aim for ligand immobilization to 1000 RU. Running buffer was 
HEPES-buffered saline-EP (HBS-EP), which contains 10 mM HEPES (pH 7.4), 
0.15 M NaCl, 3 mM EDTA, 0.005% (v/v) Surfactant P20 (Biacore AB, Uppsala, 
Sweden). Analytes were dissolved in running buffer and binding experiments 
were performed at 25°C with a flow rate of 30 ml/minute. The association phase 
(kon) was followed for 180 s, while the dissociation phase (koff) was followed for 
300 s. The complete dissociation of active complex formed was achieved by 
addition of 10 mM Hepes, 2 M NaCl, 3 mM EDTA, 0.005% (v/v) P20, pH 7.4 
for 60 s before each new cycle start. Analytes were tested in a wide range of 
concentrations, in order to reach at least a two-fold increase from lower 
concentration tested. When experimental data met quality criteria, kinetic 
parameters were estimated according to a 1:1 binding model using Biacore X100 
Evaluation Software. Conversely, an affinity steady state model was applied to 
fit the data. In this latter case two possible situations were exploited:  
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a) single binding site, using the equation y = Rmax*[Analyte] / ([Analyte] + 
KD) 
b) Double independent binding site, using the equation  
y = Rmax*[Analyte] /([Analyte] + KD) + Rmax1*[Analyte] /([Analyte] + KD1) 
 
5.6 Circular Dichroism 
All circular dichroism experiments were performed using a Jasco J710 
instrument (Jasco Inc., Easton, MD) equipped with a Peltier apparatus for 
temperature control. Static spectra of G10-loop and c-MYC oligos were 
collected at 25 °C, using oligos annealed in the appropriate buffer and 
concentrated to 20 µM. Spectra were collected using a quartz cell with 1-mm 
optical path length (Hellma, Plainview, NY) and a scanning speed of 100 
nm/min. The reported spectra are the average of five scans. To measure 
NPM1-C70 induced G-quadruplex formation, oligos dissolved in buffer 
(without additional salts) but not annealed, and concentrated to 20 µM, were 
incubated for 1 h with appropriate amounts of NPM1-C70 and spectra 
collected as above. To monitor NPM-C70 induced unfolding, oligos were 
annealed in Hepes buffer supplemented with 100 mM NaCl and incubated 
with NPM1-C70 increasing amounts. The spectral contribution of buffers and 
proteins was subtracted as appropriate. To measure the effect of the c-MYC 
and G10-loop oligos on NPM1-C70 structure, CD spectra of the protein 
(20µM) in 20mM Hepes, pH 7.0, alone or incubated with pre-annealed oligos 
(20 µM) were recorded. The spectral contribution of the oligo alone was then 
recorded and subtracted as appropriate. Thermal denaturation experiments 
were performed using a quartz cell with 1-mm optical path length and 
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monitoring the variation of CD signal at 260 nm. Temperature was 
progressively increased, in 1 °C/min steps, from 25 to 105 °C. The 
Kaleidagraph software was used for CD spectra analysis and representation. 
 
5.7 Structure calculations of the free protein 
The 1H, 13C, and 15N resonance frequencies of NPM1-C70 were assigned 
using all classical NMR experiments. NMR experiments used for resonance 
assignment and structure calculations were performed on 13C, 15N labeled 
NPM1-C70 sample containing 10% D2O. NMR spectra were collected at 298 
K, processed using standard Bruker software (TOPSPIN 2.1), and analyzed 
with CARA (Keller 2004). Structure calculations were performed with the 
software package UNIO, using as input the amino acid sequence, the 
chemical shift lists, and three 1H-1H NOE experiments: two dimensional 
NOESY, three-dimensional 13C-edited NOESY, and three-dimensional 15N-
edited NOESY, recorded at 900 MHz with a mixing time of 100 ms. The 
standard protocol, included in UNIO, with seven cycles of peak picking using 
ATNOS (Herrmann et al. 2002), NOE assignment with CANDID (Herrmann 
et al. 2002), and structure calculation with CYANA-2.1 (Gunter 2004) was 
used. φ and ψ dihedral angles were obtained from the chemical shift analysis 
using TALOS+ software (Wishart et al. 1994, Eghbalnia et al. 2005, Shen et 
al. 2009). 
In each ATNOS/CANDID cycle, the angle constraints were combined with 
the updated NOE upper distance constraints in the input for subsequent 
CYANA-2.1 structure calculation cycle. 
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The 20 conformers with the lowest target function values were subjected to 
restrained energy minimization in explicit water with AMBER 11.0 (Bertini 
et al. 2011, Case et al. 2010). NOE and torsion angle constraints were used. 
The quality of the structures was evaluated using the programs PROCHECK, 
PROCHECK NMR (Laskowski et al. 1996) and WHATIF (Vriend 1990). 
Statistics about the energyminimized family of conformers are reported in 
Table 3.4. The atomic coordinates and structural restraints for NPM1-C70 
have been deposited in the Protein Data Bank with accession code 2llh. 
Resonance assignments are also available at the BioMagResBank (accession 
number 18048). 
 
 
5.8 Structure calculations of the complex 
To identify intermolecular NOEs in the NPM1-C70/Pu24I complex, a ω1-
13Cedited, ω2-
13
C-filtered NOESY experiment was recorded in a 2D plane 
(
1
H-
1
H plane) on 
13
C,
15
N NPM1-C70/unlabelled Pu24I (Zwahlen et al. 1997). 
The selected temperature was 290 K and the mixing time used was 120 ms. 
1
H, 
13
C, 
15
N backbone resonances of NPM1-C70 in the complex were 
assigned performing all the typical experiments for backbone assignment. 
To calculate a structural model for the interaction between NPM1-C70 and 
Pu24I, a data-driven molecular docking was performed using the 
HADDOCK protocol. HADDOCK comprises a series 
of Python scripts that run on top of the structure determination programs 
ARIA and CNS (Dominguez et al. 2003, Brunger et al. 1998, Linge et al. 
2001, Linge at al. 2003, de Vries et al. 2010). The method relies on the 
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definition of Ambiguous Interaction Restraints (AIRs) derived from 
experimental data. For our docking calculations we defined as unambiguous 
restraints residues resulting from intermolecular NOEs cross-peaks on both 
protein and DNA. Furthermore we defined as AIRs: i) residues experiencing 
chemical shifts variations above the average variations plus one standard 
deviation (<δHN> = 0.043 ± 0.025 ppm, Black line in Fig. 3.10B), ii) 
Residues whose signals broadened their linewidth (Glu245, Lys248, Phe268) 
and/or disappeared during the titration (Phe276) and iii) DNA atoms 
interacting with the protein, identified also by chemical shift perturbation, as 
detected in homonuclear experiments (1D and 2D). Residues used as AIRs 
are listed in Table 3.5. The HADDOCK docking protocol consists of: (i) 
randomization of orientation and rigid body minimization, (ii) semirigid 
simulated annealing in torsion angle space, (iii) final refinement in Cartesian 
space with explicit solvent. The rigid body docking step was performed five 
times, with 1000 structures generated at each stage, the best 200 of which 
were refined in the semiflexible stage and subsequently in explicit water. 
Electrostatic and van der Waals terms were calculated with a 8.5 Å distance 
cutoff. (Dominguez et al. 2003). For the docking procedure, the structures of 
NPM1-C70 and Pu24I (PDB code 2A5P) were used as starting points. 
Heteronuclear relaxation experiments were performed on 
15
Nlabeled samples 
of NPM1-C70 at 700 MHz. The 
15
N backbone longitudinal (R1) and 
transverse (R2) relaxation rates as well as heteronuclear 
15
N{
1
H} NOEs were 
measured using a standard protocol (Orekhov et al. 1994, Farrow et al.1994). 
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